Long-Term Pattern of HIV-1 RNA Load in Perinatally Infected Children

REFERENCES

• Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167–70.
   PubMed Web of Science ®Google Scholar
• Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society—USA panel. JAMA 1997; 277: 1962–9.
   Google Scholar
• De Rossi A, Masiero S, Giaquinto C, Ruga E, Comar M, Giacca M, et al. Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest 1996; 97: 323–30.
   PubMed Web of Science ®Google Scholar
• Palumbo PE, Raskino C, Fiscus S, Pahwa S, Fowler MG, Spector SA, et al. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA 1998; 279: 756–61.
   PubMed Web of Science ®Google Scholar
• Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997; 336: 1337–42.
   PubMed Web of Science ®Google Scholar
• Valentine ME, Jackson CR, Vavro C, Wilfert CM, McCler- non D, et al. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis J 1998; 17: 18–23.
   PubMedGoogle Scholar
• McIntosh K, Shevitz A, Zaknun D, Kornegay J, Chatis P, Karthas N, et al. Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus. Pediatr Infect Dis J 1996; 15: 1087–91.
   PubMed Web of Science ®Google Scholar
• Paediatric European Network for Treatment of AIDS (PENTA). HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. AIDS 1998; 12: F1–8.
   Google Scholar
• The European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection, Pediatrics 1994; 94: 815–9.
   Google Scholar
• Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173–80.
   PubMed Web of Science ®Google Scholar
• Connor EM, Mofenson LM. Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076—results and treatment recommendations. Pediatr Infect Dis J 1995; 14: 536–41.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994; 43: 1–10.
   Google Scholar
• van Gemen B, v d Wiel P, van Beuningen R, Sillekens P, Jurriaans S, Dries C, et al. The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. PCR Methods Appl 1995; 4: S177–84.
   Google Scholar
• Leitner T, Korovina G, Marquina S, Smolskaya T, Albert J. Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant. AIDS Res Hum Retroviruses 1996; 12: 1595–603.
   PubMed Web of Science ®Google Scholar
• Goudsmit J. Prevention and clinical management of AIDS. In: The NASBA experience in HIV-1 quantification. Amsterdam: Amsterdam University Press, 1996: 40–1.
   Google Scholar
• Ginocchio CC, Wang XP, Kaplan MH, Mulligan G, Witt D, Romano JW, et al. Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol 1997; 35: 2886–93.
   PubMedGoogle Scholar
• Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997; 11: 199–202.
   PubMed Web of Science ®Google Scholar
• Alaeus A, Lidman K, Sonnerborg A, Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 1997; 11: 859–65.
   PubMedGoogle Scholar
• Oudshoorn P, Jacobs F, Ehren R, de Baar M, van Aarle P, de Ronde T. Detection and quantitation of HIV-1 variants by a LTR-based NASBA assay. 12th World AIDS Conference. Geneva, June 28 -July 3 1998 (abstract 41258).
   Google Scholar
• Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179: 68–73.
   PubMed Web of Science ®Google Scholar
• Dickover RE, Dillon M, Gillette SG, Deveikis A, Keller M, Plaeger-Marshall S, et al. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994; 170: 1279–84.
   PubMed Web of Science ®Google Scholar
• Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991; 324: 961–4.
   PubMed Web of Science ®Google Scholar
• Henrard DR, Phillips JF, Muenz LR, Blattner WA, Wiesner D, Eyster ME, et al. Natural history of HIV-1 cell-free viremia. JAMA 1995; 274: 554–8.
   PubMed Web of Science ®Google Scholar
• Garcia F, Vidal C, Gatell JM, Miro JM, Soriano A, Pumarola T. Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 × 10(6)/l. AIDS 1997; 11: 53–7.
   PubMedGoogle Scholar